Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
The Open Rheumatology Journal|July 22, 2010
Nuclear Pore Protein p62 Autoantibodies in Systemic Lupus ErythematosusDoris M Kraemer, Hans-Peter TonyImmunobiology|February 28, 2003
Effective B cell depletion with rituximab in the treatment of autoimmune diseasesChristian Kneitz, Martin Wilhelm, Hans Peter TonyArthritis and Rheumatism|June 3, 2008
Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatmentPetra Roll, Thomas Dörner, Hans-Peter TonyClinics in Dermatology|November 21, 2007
Psoriatic arthritis: clinical spectrum and diagnostic proceduresStefan Kleinert, Martin Feuchtenberger, Christian Kneitz, et al.Clinics in Dermatology|August 30, 2008
Psoriatic arthritis: therapeutic principlesMartin Feuchtenberger, Stefan Kleinert, Hans-Peter Tony, et al.Annals of the New York Academy of Sciences|September 26, 2007
Sun-induced life-threatening lupus nephritisEnno Schmidt, Hans-Peter Tony, Eva-Bettina Bröcker, et al.The Open Rheumatology Journal|May 30, 2009
Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case ReportMartin Feuchtenberger, Christian Kneitz, Petra Roll, et al.Arthritis and Rheumatism|August 1, 2009
Delayed acquisition of somatic hypermutations in repopulated IGD+CD27+ memory B cell receptors after rituximab treatmentKhalid Muhammad, Petra Roll, Hermann Einsele, et al.Clinical and Diagnostic Laboratory Immunology|March 11, 2003
Nucleoporin p62 antibodies in a case of mixed connective tissue diseaseDoris M Kraemer, Michael R Kraus, Christian Kneitz, et al.Arthritis and Rheumatism|July 27, 2006
Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritisPetra Roll, Arumugam Palanichamy, Christian Kneitz, et al.Pageof 11